Entero Healthcare Solutions Current Share Price | Entero Healthcare Solutions Stock Screener
ENTERO
Pharmacy Retail
Entero Healthcare Solutions Current Stock Price Today
Live Share Price NSE
₹1732.30
▲
65.70 (3.94%)
Live Share Price BSE
₹1733.00
▲
67.95 (4.08%)
As of September 18, 2026, the live Entero Healthcare Solutions share price (NSE: ENTERO) is ₹1,732.30 on NSE and ₹1,733.00 on BSE, up 3.94% from the previous close, with shares trading between ₹1,669.90 and ₹1,737.80 in today's trading session, and a 52-week range of ₹949.20–₹1,898.40.
Browse Entero Healthcare Solutions financial data to support your investment research.
Use the Entero Healthcare Solutions stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Entero Healthcare Solutions Market Cap
₹7,842.41 Cr.
ENTERO P/E Ratio (TTM)
47.23
Entero Healthcare Solutions P/B Ratio
4.65
EPS (TTM)
₹26.44
Dividend Yield
-
Debt to Equity
0.31
ENTERO 52 Week High
₹1898.40
Entero Healthcare Solutions 52 Week Low
₹949.20
Operating Margin
5.00%
Profit Margin
2.67%
ENTERO Revenue (TTM)
₹1,944.00
EBITDA
₹100.00
Net Income
₹52.00
Total Assets
₹3,600.00
Total Equity
₹1,753.00
Entero Healthcare Solutions Current Share Price Chart
Track the current Entero Healthcare Solutions share price and stock price with an interactive chart. Analyse ENTERO price trends, trading volume, historical performance, and volatility across different timeframes — the complete Entero Healthcare Solutions stock quote in one place.
Entero Healthcare Solutions Company Profile - Fundamental Screener
Screen Entero Healthcare Solutions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ENTERO shares.
Sector
Retail
Industry
Pharmacy Retail
Sub-Sector
Pharmacy Retail
Segment
E
ISIN
INE010601016
Entero Healthcare Solutions Balance Sheet Screener
Screen ENTERO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 3,600 | 2,703 | 2,345 | 1,309 | 1,126 | 836 | 749 |
| Current Assets | 2,508 | 2,076 | 2,011 | 1,023 | 851 | 636 | 552 |
| Fixed Assets | 958 | 559 | 289 | 268 | 262 | 189 | 186 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 260 | 87 | 102 | 87 | 101 | 58 | 56 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 1,753 | 1,770 | 1,641 | 598 | 563 | 487 | 424 |
| Share Capital | 44 | 44 | 44 | 4 | 4 | 517 | 439 |
| Reserves & Surplus | 1,639 | 1,676 | 1,593 | -73 | -62 | -32 | -16 |
Entero Healthcare Solutions Income Statement Screener - Profit & Revenue Analysis
Screen Entero Healthcare Solutions income statement and profit fundamentals.
Analyze ENTERO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Entero Healthcare Solutions share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,944 | 1,914 | 1,711 | 1,576 | 1,410 | 1,346 | 1,367 | 1,312 | 1,111 | 1,043 | 994 | 998 | 901 | 888 | 832 |
| Expenses | 1,844 | 1,824 | 1,647 | 1,509 | 1,354 | 1,290 | 1,309 | 1,258 | 1,067 | 1,005 | 964 | 968 | 873 | 867 | 810 |
| EBITDA | 100 | 90 | 64 | 67 | 56 | 56 | 58 | 54 | 44 | 38 | 30 | 31 | 27 | 21 | 21 |
| Operating Profit % | 5.00% | 5.00% | 3.00% | 4.00% | 4.00% | 4.00% | 4.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 2.00% | 2.00% |
| Depreciation | 12 | 15 | 10 | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 5 |
| Interest | 21 | 17 | 14 | 12 | 11 | 11 | 10 | 12 | 10 | 17 | 16 | 18 | 14 | 13 | 13 |
| Profit Before Tax | 67 | 58 | 40 | 45 | 36 | 37 | 39 | 35 | 27 | 14 | 8 | 7 | 7 | 1 | 3 |
| Tax | 15 | 13 | 7 | 8 | 6 | 6 | 10 | 9 | 7 | -8 | 1 | 2 | 0 | 5 | -1 |
| Net Profit | 52 | 45 | 34 | 37 | 30 | 31 | 30 | 26 | 21 | 21 | 7 | 5 | 6 | -4 | 4 |
| EPS | 8.77 | 6.44 | 6.35 | 7.26 | 6.39 | 5.91 | 5.85 | 5.43 | 4.62 | 5.73 | 4.21 | 3.24 | 15.18 | 1.49 | 8.67 |
Entero Healthcare Solutions Cash Flow Screener - Liquidity Fundamentals
Screen ENTERO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 96 | -77 | -37 | -45 | -35 | -69 | -37 |
| Investing Activities | -302 | 232 | -704 | -49 | -162 | -31 | -203 |
| Financing Activities | 124 | -74 | 863 | 73 | 211 | 89 | 217 |
| Net Cash Flow | -82 | 82 | 122 | -21 | 14 | -11 | -23 |
Entero Healthcare Solutions Shareholding Pattern Screener
See Entero Healthcare Solutions shareholding pattern with promoter, FII, and DII holdings.
Check Entero Healthcare Solutions promoter holding and ownership changes for ENTERO on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.42% | 52.40% | 52.42% | 52.42% | 52.42% | 52.42% | 52.44% | 52.44% |
| FII Holding | 4.03% | 4.37% | 19.92% | 17.20% | 14.67% | 5.14% | 0.00% | 23.30% |
| DII Holding | 16.62% | 15.48% | 9.64% | 10.18% | 9.65% | 16.42% | 1.36% | 2.28% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.25% | 13.05% | 5.41% | 6.99% | 9.36% | 11.56% | 5.72% | 4.95% |
| Other Holding | 14.68% | 14.70% | 12.61% | 13.20% | 13.90% | 14.46% | 40.48% | 17.03% |
| Shareholder Count | 39,084 | 39,710 | 33,159 | 33,338 | 36,334 | 40,333 | 58 | 80,864 |
Entero Healthcare Solutions Share Dividend Screener - Share Yield Analysis
Check Entero Healthcare Solutions dividend history with payout and yield data.
View Entero Healthcare Solutions dividend details including ex-dates and amounts for ENTERO stock.
Entero Healthcare Solutions Stock Index Membership
See which indices include Entero Healthcare Solutions stock.
Check ENTERO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE Consumer Discretionary Index
BSE INDEX SMLCAP
NIFTY IPO
NIFTY MICROCAP250
NIFTY TOTAL MKT
Entero Healthcare Solutions Market Events Screener - Corporate Actions
Get Entero Healthcare Solutions corporate actions including splits, bonuses, and buybacks.
Check Entero Healthcare Solutions stock events that may affect ENTERO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-19 | 2026-08-19 | Annual General Meeting | NA | 3.97% |
| 2026-08-07 | 2026-08-07 | Quarterly Result Announcement | NA | -2.43% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 13.55% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 1.49% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.01% |
| 2025-09-18 | 2025-09-18 | Annual General Meeting | NA | -2.28% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.69% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 2.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.18% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 6.49% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 4.51% |
Entero Healthcare Solutions Competitors Screener - Peer Comparison
Screen ENTERO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Medplus Health Services | 7,885 | 37.69 | 6,964 | 12.60% | 220 | 39.83 |
| Entero Healthcare Solutions | 7,842 | 47.23 | 6,610 | 28.72% | 146 | 67.52 |
| Trimurthi | 220 | 9 | -4.17% | -2 | 56.59 | |
| Vijaypd Ceutical | 127 | 25.39 | 103 | 1.98% | 5 | 49.68 |
Entero Healthcare Solutions Company Announcements - News Screener
Screen ENTERO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-18 | Entero Healthcare Solutions Limited Has Informed The Exchange About General Updates | - |
| 2026-08-26 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-19 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-19 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-07 | Unaudited Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-08-07 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 07 2026 | - |
| 2026-08-05 | Revised Intimation Of The Earnings Call | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-07-30 | Updated Annual Report Of The Company For The Financial Year 2025-26 | - |
| 2026-07-28 | Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results (Along With Limited Review Report) For The Quarter Ended June 30 2026. | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-27 | Annual Report For The Financial Year 2025-26 Along With The Notice Convening The 8Th Annual General Meeting | - |
| 2026-07-27 | Intimation Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With Company/ Registrar And Share Transfer Agent/Depository Participant(S). | - |